Friday 6 November 2026
Export PDEX’s income statement to Excel — free account
Pro-Dex, Inc.
PDEX Healthcare Medical Instruments & Supplies
Pro-Dex, Inc.’s revenue for fiscal 2026 (year ended June 2026) was $77.5 million, up 16.5% from fiscal 2025.
- Revenue
- +11.0%
- EPS
- −33.6%
- Free cash flow
- +177.8%
- Total debt
- +42.2%
Quarter to September 2026, against a year earlier
62.75
1.55
+2.53%
Follow PDEX
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 5 | 7 |
+8 more TTM periods Free account |
| 26.48% | 32.43% | 29.83% | 30.87% | ||
| 17.08% | 20.14% | 17.24% | 18.49% | ||
ROIC |
17.22% | 15.75% | 13.92% | 17.38% | |
Return on Tangible Assets |
22.97% | 26.47% | 23.72% | 23.74% | |
Average Days of Receivables |
85.26 | 102.73 | 96.70 | 91.88 | |
Free Cash Flow per Share |
3.33 | 2.10 | 2.18 | 1.85 | |
Free Cash Flow |
10.69 | 6.76 | 6.97 | 6.02 | |
Capital Expenditures |
(0.73) | (0.48) | (0.37) | (0.44) | |
| Other line items | |||||
Cash ROIC |
14.33% | 9.62% | 9.89% | 10.30% | |
Accounts Receivable Turnover |
4.31 | 3.95 | 4.19 | 3.94 | |
Accounts Payable Turnover |
11.58 | 11.99 | 9.62 | 10.55 | |
Inventory Turnover |
2.47 | 2.44 | 2.35 | 2.50 | |
Average Days of Payables |
36.13 | 29.23 | 35.52 | 29.02 | |
Days of Inventory on Hand |
148.70 | 147.19 | 151.39 | 153.26 | |
Tax Rate |
(0.21) | (0.24) | (0.25) | (0.26) | |
Research and Development Expense of Revenue |
4.76% | 4.31% | 4.33% | 4.65% | |
Selling, General and Administrative Expense of Revenue |
10.86% | 10.31% | 8.97% | 7.90% | |
Share Based Compensation of Revenue |
0.83% | 0.89% | 0.89% | 0.88% | |
Interest Coverage |
15.36 | 16.00 | 14.05 | 13.95 | |
Operating CF/Net income |
0.95 | 0.53 | 0.61 | 0.57 | |
Depreciation/Fixed assets |
0.13 | 0.12 | 0.11 | 0.12 | |
Capex/Depreciation |
(0.49) | (0.34) | (0.29) | (0.35) | |
Revenue per Share |
24.82 | 24.04 | 23.32 | 22.19 | |
Operating CF per Share |
3.56 | 2.24 | 2.29 | 1.99 | |
Capex per Share |
(0.23) | (0.15) | (0.12) | (0.14) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates · fundamentals updated 5 Nov 2026